** U.S.-listed shares of Switzerland-based biotechnology co
EARS.O down 33.37% at $3.48
** Co enters into agreements with institutional investors
for purchase and sale of 2 mln common shares at an offer price
of $4.00 per share - discount of 23.51% to stock's last close
urn:newsml:reuters.com:*:nGNX4b8kkh
** Gross proceeds of the offering will be about $8 mln
** Co intends to use net proceeds for working capital and
general corporate purposes
** Offering expected to close on or about Dec. 4
** Stock has gained 112.96% so far this year
(Reporting by Rithika Krishna)
((Rithika.Krishna@thomsonreuters.com;))